Monitoring ARIA in Anti-Amyloid Therapy in Alzheimer's
Advancements in Alzheimer's treatment focus on early intervention via antiamyloid-beta monoclonal antibodies to target disease causes rather than just symptoms.
Controversial New Guidelines Would Diagnose Alzheimer's Before Symptoms Appear
Early detection of Alzheimer's disease is crucial for effective treatment and management.
Study says scientists may be able to 'listen' for Alzheimer's disease
Detection of Alzheimer's may be more effective through auditory analysis rather than eye movement, using an innovative device to track eardrum vibrations.
Monitoring ARIA in Anti-Amyloid Therapy in Alzheimer's
Advancements in Alzheimer's treatment focus on early intervention via antiamyloid-beta monoclonal antibodies to target disease causes rather than just symptoms.
Controversial New Guidelines Would Diagnose Alzheimer's Before Symptoms Appear
Early detection of Alzheimer's disease is crucial for effective treatment and management.
Study says scientists may be able to 'listen' for Alzheimer's disease
Detection of Alzheimer's may be more effective through auditory analysis rather than eye movement, using an innovative device to track eardrum vibrations.
Alzheimer's timeline shows changes start as trickle, become torrent
Alzheimer's disease has two distinct phases, indicating a slow onset followed by rapid deterioration, with vulnerable neurons identified for potential early treatment.
Non-Neuron Brain Cells Produce a Third of Amyloid Plaque in Alzheimer's Disease - News Center
Oligodendrocytes contribute to about one-third of amyloid plaque formation in Alzheimer's disease, challenging previous understanding and informing new therapies.
Can flashing lights stall Alzheimer's? What the science shows
Immersive audiovisual experiences may help combat Alzheimer's symptoms, showing promise in stabilizing cognitive decline in patients.
This metabolic brain boost revives memory in Alzheimer's mice
An experimental cancer drug has shown promise in re-energizing the brains of Alzheimer's mice, indicating potential new treatment methods.
One day, we may all have brain chips to help remember where our keys are: scientists
Kahana's research shows potential for brain stimulation to significantly improve memory recall.
Cellular communities reveal trajectories of brain ageing and Alzheimer's disease - Nature
The study presents a new understanding of Alzheimer's disease by identifying unique cellular trajectories and populations linked to its onset.
Alzheimer's timeline shows changes start as trickle, become torrent
Alzheimer's disease has two distinct phases, indicating a slow onset followed by rapid deterioration, with vulnerable neurons identified for potential early treatment.
Non-Neuron Brain Cells Produce a Third of Amyloid Plaque in Alzheimer's Disease - News Center
Oligodendrocytes contribute to about one-third of amyloid plaque formation in Alzheimer's disease, challenging previous understanding and informing new therapies.
Can flashing lights stall Alzheimer's? What the science shows
Immersive audiovisual experiences may help combat Alzheimer's symptoms, showing promise in stabilizing cognitive decline in patients.
This metabolic brain boost revives memory in Alzheimer's mice
An experimental cancer drug has shown promise in re-energizing the brains of Alzheimer's mice, indicating potential new treatment methods.
One day, we may all have brain chips to help remember where our keys are: scientists
Kahana's research shows potential for brain stimulation to significantly improve memory recall.
Cellular communities reveal trajectories of brain ageing and Alzheimer's disease - Nature
The study presents a new understanding of Alzheimer's disease by identifying unique cellular trajectories and populations linked to its onset.
AlzPath's blood test for ptau217 offers early Alzheimer’s detection, crucial for timely treatment as new therapies develop.
A Blood Test Accurately Diagnosed Alzheimer's 90% of the Time, Study Finds
A blood test for Alzheimer's disease shows 90% accuracy compared to cognitive tests and CT scans, revolutionizing diagnosis possibilities.
A new Alzheimer's study suggests where you live can affect the odds of a diagnosis
Diagnosis rates for Alzheimer's vary significantly across the U.S., potentially influenced by stigma and access to healthcare.
Blood tests for Alzheimer's may be coming to your doctor's office. Here's what to know
New blood tests for Alzheimer's show promise, but their accuracy varies. Current tests lack widespread use, FDA approval, insurance coverage, and consensus on reliability.
Blood Tests for Alzheimer's May Be Coming to Your Doctor's Office
New blood tests for Alzheimer's are promising but need more evidence for widespread adoption.
What are the symptoms of dementia and how do you get a diagnosis?
Dementia is a group of related symptoms associated with a decline in brain function, with Alzheimer's disease being the most common subtype.
Symptoms of dementia can affect memory, thinking, behavior, mood, and daily activities, and typically worsen over time.
A Blood Test for Alzheimer's
AlzPath's blood test for ptau217 offers early Alzheimer’s detection, crucial for timely treatment as new therapies develop.
A Blood Test Accurately Diagnosed Alzheimer's 90% of the Time, Study Finds
A blood test for Alzheimer's disease shows 90% accuracy compared to cognitive tests and CT scans, revolutionizing diagnosis possibilities.
A new Alzheimer's study suggests where you live can affect the odds of a diagnosis
Diagnosis rates for Alzheimer's vary significantly across the U.S., potentially influenced by stigma and access to healthcare.
Blood tests for Alzheimer's may be coming to your doctor's office. Here's what to know
New blood tests for Alzheimer's show promise, but their accuracy varies. Current tests lack widespread use, FDA approval, insurance coverage, and consensus on reliability.
Blood Tests for Alzheimer's May Be Coming to Your Doctor's Office
New blood tests for Alzheimer's are promising but need more evidence for widespread adoption.
What are the symptoms of dementia and how do you get a diagnosis?
Dementia is a group of related symptoms associated with a decline in brain function, with Alzheimer's disease being the most common subtype.
Symptoms of dementia can affect memory, thinking, behavior, mood, and daily activities, and typically worsen over time.
A Simple Blood Test Outperformed Doctors in Spotting This Devastating Memory Disease
A blood test can identify Alzheimer's disease more accurately than traditional methods.
Can One Protein Make a Difference in Preventing Alzheimer's?
The discovery of a genetic resilience to early onset Alzheimer's, linked to the protein Reelin, poses new possibilities for Alzheimer's treatments.
Francisco Lopera, Pioneer in Alzheimer's Research, Dies at 73
Dr. Francisco Lopera significantly advanced Alzheimer's research through his work with a large Colombian family, identifying genetic causes and focusing on care for affected patients.
Researchers identify new genetic form of Alzheimer's that is present in millions of people
Study highlights the implications of predicting Alzheimer's disease at a 100% probability and the potential impact on individuals' lives.
2021: Anti-amyloid antibodies take a bumpy road to the clinic
The initial disease-modifying therapy for Alzheimer's sparked complex reactions rather than unbridled joy.
A Simple Blood Test Outperformed Doctors in Spotting This Devastating Memory Disease
A blood test can identify Alzheimer's disease more accurately than traditional methods.
Can One Protein Make a Difference in Preventing Alzheimer's?
The discovery of a genetic resilience to early onset Alzheimer's, linked to the protein Reelin, poses new possibilities for Alzheimer's treatments.
Francisco Lopera, Pioneer in Alzheimer's Research, Dies at 73
Dr. Francisco Lopera significantly advanced Alzheimer's research through his work with a large Colombian family, identifying genetic causes and focusing on care for affected patients.
Researchers identify new genetic form of Alzheimer's that is present in millions of people
Study highlights the implications of predicting Alzheimer's disease at a 100% probability and the potential impact on individuals' lives.
2021: Anti-amyloid antibodies take a bumpy road to the clinic
The initial disease-modifying therapy for Alzheimer's sparked complex reactions rather than unbridled joy.
Dementia: Healthier lifestyles could prevent it DW 08/02/2024
Scientists found dementia risks can be reduced significantly with 14 health factors.
New risk factors for dementia include high cholesterol and vision loss.
Memory Loss Isn't the Only Sign of Dementia
Financial mismanagement can signal early brain changes related to dementia, particularly in frontotemporal dementia patients who exhibit altered judgment.
Is the 100-year old TB vaccine a new weapon against Alzheimer's?
The BCG vaccine was initially developed to fight bovine tuberculosis, but it led to the creation of a vaccine that has saved millions of lives.
Preliminary studies suggest that the BCG vaccine could protect against Alzheimer's disease, potentially offering a cost-effective solution in the fight against dementia.
Dementia: Healthier lifestyles could prevent it DW 08/02/2024
Scientists found dementia risks can be reduced significantly with 14 health factors.
New risk factors for dementia include high cholesterol and vision loss.
Memory Loss Isn't the Only Sign of Dementia
Financial mismanagement can signal early brain changes related to dementia, particularly in frontotemporal dementia patients who exhibit altered judgment.
Is the 100-year old TB vaccine a new weapon against Alzheimer's?
The BCG vaccine was initially developed to fight bovine tuberculosis, but it led to the creation of a vaccine that has saved millions of lives.
Preliminary studies suggest that the BCG vaccine could protect against Alzheimer's disease, potentially offering a cost-effective solution in the fight against dementia.
Leonard Riggio, founder of Barnes & Noble, died at 83 after battling Alzheimer's, leaving behind a significant legacy in retail and entrepreneurship.
Leonard Riggio, who forged a bookselling empire at Barnes & Noble, dead at 83
Leonard Riggio revolutionized the publishing industry with Barnes & Noble, fostering a culture of innovation and accessibility before passing away at age 83.
Brooklyn remembers Leonard Riggio, who expanded Barnes & Noble into an empire
Leonard Riggio, influential in transforming Barnes & Noble, passed away at 83, leaving a legacy in bookselling and his community.
Barnes & Noble founder Leonard Riggio dies at 83
Leonard Riggio, founder of Barnes & Noble, died at 83 after battling Alzheimer's, leaving behind a significant legacy in retail and entrepreneurship.
Leonard Riggio, who forged a bookselling empire at Barnes & Noble, dead at 83
Leonard Riggio revolutionized the publishing industry with Barnes & Noble, fostering a culture of innovation and accessibility before passing away at age 83.
Brooklyn remembers Leonard Riggio, who expanded Barnes & Noble into an empire
Leonard Riggio, influential in transforming Barnes & Noble, passed away at 83, leaving a legacy in bookselling and his community.
Plastic in our brains: Study shows a 50% increase in just 8 years
The presence of micro and nano plastics in human brains has increased by 50% from 2016 to 2024, raising health concerns.
Nocturnal Hot Flashes and Alzheimer's Risk
Nighttime vasomotor symptoms (VMS) during menopause may indicate a higher risk of Alzheimer's disease, highlighting the potential link between VMS and brain health.
Scientists Find Human Brains Are Getting Larger and Larger
Bigger brains may help stave off dementia
Larger brains could be tied to improved brain health
Plastic in our brains: Study shows a 50% increase in just 8 years
The presence of micro and nano plastics in human brains has increased by 50% from 2016 to 2024, raising health concerns.
Nocturnal Hot Flashes and Alzheimer's Risk
Nighttime vasomotor symptoms (VMS) during menopause may indicate a higher risk of Alzheimer's disease, highlighting the potential link between VMS and brain health.
Scientists Find Human Brains Are Getting Larger and Larger
Bigger brains may help stave off dementia
Larger brains could be tied to improved brain health
Gena Rowlands, The Notebook Actress and Film Icon, Dead at 94
Gena Rowlands, acclaimed actress known for iconic films, passed away at 94 after battling Alzheimer's disease.
Gena Rowlands, star of A Woman Under the Influence and Gloria, dies at 94
Gena Rowlands, acclaimed actress and three-time Emmy winner, has passed away at 94, celebrated for her impactful roles and collaborative work with John Cassavetes.
The Notebook star Gena Rowlands dies at 94
Gena Rowlands, iconic actress and long-time collaborator with husband John Cassavetes, leaves a legacy of groundbreaking female-centric films.
Gena Rowlands, star of 'The Notebook,' dead at 94
Gena Rowlands, celebrated actress and independent film pioneer, passed away at age 94, leaving a profound legacy in cinema.
Gena Rowlands, The Notebook Actress and Film Icon, Dead at 94
Gena Rowlands, acclaimed actress known for iconic films, passed away at 94 after battling Alzheimer's disease.
Gena Rowlands, star of A Woman Under the Influence and Gloria, dies at 94
Gena Rowlands, acclaimed actress and three-time Emmy winner, has passed away at 94, celebrated for her impactful roles and collaborative work with John Cassavetes.
The Notebook star Gena Rowlands dies at 94
Gena Rowlands, iconic actress and long-time collaborator with husband John Cassavetes, leaves a legacy of groundbreaking female-centric films.
Gena Rowlands, star of 'The Notebook,' dead at 94
Gena Rowlands, celebrated actress and independent film pioneer, passed away at age 94, leaving a profound legacy in cinema.
How Hearing and Vision Loss Increase the Risk of Dementia
Vision loss in adults over 65 increases dementia risk by 50%, but correcting vision problems can significantly reduce the risk.
Blood tests may have an edge spotting Alzheimer's
Blood tests can accurately diagnose Alzheimer's, aiding early treatment with potential over existing methods like PET scans and spinal taps.
Luke O'Neill: Are we seeing the beginning of the end for the devastating disease that is Alzheimer's?
A new drug called Kisunla has been approved by the FDA to treat early symptoms of Alzheimer's disease.
Black men are a hidden segment of caregivers. It's stressful but rewarding, too
Black male caregivers face unique challenges.
GLP-1-directed NMDA receptor antagonism for obesity treatment - Nature
NMDA receptor blockers show promise for treating obesity by reducing food intake and body weight through neurostructural changes and synaptic plasticity.
Controversial scientist says he'll use gene editing to end HIV & Alzheimer's
Controversial Chinese scientist He Jiankui faces consequences for gene-editing experiments on twins.
Despite criticism, He now aims to use 'base editing' to prevent Alzheimer's disease, setting the stage for potential breakthroughs in curing other diseases.
Diabetes drugs test a new side effect: slowing down symptoms of Parkinson's
GLP-1 receptor agonists have potential benefits beyond just treating diabetes and obesity, potentially impacting diseases like Alzheimer's and Parkinson's positively.
Yoga provides unique cognitive benefits to older women at risk of Alzheimer's disease
Kundalini yoga benefits cognition and memory in older women at risk of Alzheimer's.
UCLA study compared effects of yoga and memory training on cognitive decline.
Researchers find association between air pollution and Alzheimer's